Yan Ji
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
- Oncology 30
- Cancer-related Molecular Pathways 8
- HER2/EGFR in Cancer Research 5
- Drug Transport and Resistance Mechanisms 5
-
- Advanced Breast Cancer Therapies 19
- Co-authors
- Marilyn E. Morris (6 shared papers)George P. Studzinski (4 shared papers)Nanjoo Suh (7 shared papers)Hong Jin Lee (6 shared papers)Handong Wang (3 shared papers)Wei Xing Yan (3 shared papers)Gang Chen (2 shared papers)Yuhsin Kuo (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Frontiers in Immunology (3 papers)Clinical and Translational Science (3 papers)Biochemical Pharmacology (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Yan Ji
109 papers receiving 3.4k citations
Yan Ji's Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 433
- Oncology 712
- Geriatrics and Gerontology 72
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 582
Countries citing papers authored by Yan Ji
This map shows the geographic impact of Yan Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ji more than expected).
Fields of papers citing papers by Yan Ji
This network shows the impact of papers produced by Yan Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ji. The network helps show where Yan Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ribociclib plus Endocrine Therapy in Early Breast Cancer Hit paper breakdown → | 2024 | 231 |
| 2 | Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Hit paper breakdown → | 2021 | 200 |
| 3 | 2008 | 154 | |
| 4 | 2009 | 143 | |
| 5 | 2021 | 130 | |
| 6 | 2015 | 117 | |
| 7 | 2005 | 91 | |
| 8 | 2015 | 90 | |
| 9 | 2008 | 87 | |
| 10 | 2004 | 87 | |
| 11 | 2003 | 84 | |
| 12 | 2019 | 79 | |
| 13 | 2020 | 75 | |
| 14 | 2019 | 75 | |
| 15 | 2006 | 74 | |
| 16 | 2015 | 60 | |
| 17 | 2006 | 57 | |
| 18 | 2012 | 55 | |
| 19 | 2018 | 53 | |
| 20 | 2020 | 52 |
About Yan Ji
Yan Ji is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 114 papers that have together received 3.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (19 papers), Cancer-related Molecular Pathways (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Genomics, phytochemicals, and oxidative stress (7 papers), Vitamin D Research Studies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Cancer Research (433 citations), Oncology (712 citations), Geriatrics and Gerontology (72 citations), Molecular Biology (1.4k citations) and Pulmonary and Respiratory Medicine (582 citations). Yan Ji has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Marilyn E. Morris, George P. Studzinski, Nanjoo Suh, Hong Jin Lee, Handong Wang, Wei Xing Yan, Gang Chen, Yuhsin Kuo, Shiby Paul and Bandaru S. Reddy. Their work appears in journals such as Annals of Oncology, Frontiers in Immunology, Clinical and Translational Science, Biochemical Pharmacology and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.